Sign in

CIK 0001438533

  • Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
262383102
Phone
+1 888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,495,607
in 10 filings, $79.5M under 10b5-1 plans

Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 20 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-10 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Exercise or conversion · Performance-based restricted stock units 10b5-1 −8,000 0
2025-02-10 Heerma Peter CHIEF COMMERCIAL OFFICER Exercise or conversion 10b5-1 +8,000 130,708
2025-02-10 Heerma Peter CHIEF COMMERCIAL OFFICER Exercise or conversion · Performance-based restricted stock units 10b5-1 −8,000 0
2025-02-10 Inrig Jula CHIEF MEDICAL OFFICER Exercise or conversion +8,000 92,170
2025-02-10 Inrig Jula CHIEF MEDICAL OFFICER Exercise or conversion · Performance-based restricted stock units −8,000 0
2025-02-06 Baynes Roy D. Director Exercise or conversion 10b5-1 +10,000 $17.44 $174K 41,000
2025-02-06 Baynes Roy D. Director Sale 10b5-1 −10,000 $22.00 $220K 31,000
2025-02-06 Baynes Roy D. Director Exercise or conversion · Stock option (right to buy) 10b5-1 −10,000 0
2025-02-04 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −1,066 $20.11 $21K 84,170
2025-02-03 ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D Sale 10b5-1 −8,951 $19.78 $177K 95,719
2025-02-03 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Sale 10b5-1 −8,951 $19.78 $177K 89,482
2025-02-03 Dube Eric M CHIEF EXECUTIVE OFFICER Sale 10b5-1 −50,691 $20.21 $1.0M 430,548
2025-02-03 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −4,207 $20.12 $85K 85,236
2025-02-03 Heerma Peter CHIEF COMMERCIAL OFFICER Sale −5,166 $20.12 $104K 122,708
2025-02-03 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale −5,192 $20.12 $104K 90,038
2025-02-03 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale −3,348 $20.12 $67K 63,654
2025-01-31 ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D Grant or award 10b5-1 +21,500 104,670
2025-01-31 ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D Grant or award · Employee stock option (right to buy) 10b5-1 +58,000 58,000
2025-01-31 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Grant or award 10b5-1 +21,500 98,433
2025-01-31 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Grant or award · Employee stock option (right to buy) 10b5-1 +58,000 58,000

Page 20 of 59 · 1,174 trades